Collaborators outside our lab... Collaborations or consulting for the private sectors can not be reported here for IP reasons

Dr G. Nicolaes, Cardiovascular Research Institute Maastricht, CARIM, Maastricht University, the Netherlands, Blood coagulation

Dr B. Deprez, Inserm U1177 – Lille2 University (IFR114) – Pasteur Institute Lille (IFR142), France, Medicinal chemistry

Dr N. Bonnefoy, Inserm U896, Montpellier1, France, Cancer and immunity

Dr. K. Majid, Inserm U1029, University Bordeaux 1 France, Cancer research

Dr. M. Reboud, Univ Paris 6, Paris France, Cancer research

Dr. E. Ogier-Denis, Medical Faculty Xavier Bichat France, Inserm U773-CRB3, Rare disease

Dr. P. Dariavach, UMR 5160 CNRS, Montpellier, France, Immunity and cancer

Dr. B. Dahlback, Malmo Hospital/Lund University, Sweden, Cardiovascular diseases, Blood coagulation, Cancer

Dr. J. Vidal, Univ Rennes 1, France, Medicinal chemistry - Cancer

Dr. M. Alvarado-Kristensson, Malmo Hospital/Lund University, Sweden, Cancer

Dr. A. Blom, Malmo Hospital/Lund University, Sweden, Complement system

Dr. J. Fernandez-Recio, Bacelona, Spain, Protein-protein interactions

Dr. JL. Poyet, Hospital Saint-Louis, Paris, Cancer

Dr. H. Bruzzoni-Giovanelli, Hospital Saint-Louis, Paris, Cancer

Dr. F. Leroux, Inserm U1177 – Lille2 University (IFR114) – Pasteur Institute Lille (IFR142), France, Medicinal chemistry

Dr. D. Eladari, Inserm - Hospital Felix Guyon, CHU Reunion, la Reunion, Cardiovascular diseases

Dr. J. Teulon, Univ Paris 6, Cardiovascular diseases

Dr. R. Rimokh, Lyon Cancer Institute, Cancer

Dr. G. Gillet, Lyon Cancer Institute, Cancer

Dr. J. Weitzman, Univ Paris 7, Cancer, Epigenetics

Dr. V Fremeaux-Bacchi - European Hospital Paris, Complement system

Dr. L Roumenina, Inserm Paris, Complement system

Dr. R Rezaie, Oklahoma Medical Research Foundation, USA, Blood coagulation diseases

Dr. T. Renno, Centre Léon Bérard, Lyon, Cancer

Dr. I. Coste, Centre Léon Bérard, Lyon, Cancer

Dr. S. Giraud, Centre Léon Bérard, Lyon, Cancer